Berkeley Lab-led study reveals electrostatic forces direct key enzyme used by both healthy and diseased cells
The actions of a protein used for DNA replication and repair are guided by electrostatic forces known as phosphate steering, a finding that not only reveals key details about a vital process in healthy cells, but provides new directions for cancer treatment research.
Shown is the crystal structure of the FEN1 protein bound to its target DNA. Researchers found that single-stranded flaps are threaded through a tunnel in FEN1. The unexpected inversion of the threaded flap, guided by phosphate steering, keeps the phosphodiester bonds facing away from the metals that could inadvertently shred them.
Credit: Susan Tsutakawa/Berkeley Lab
The findings, published this week in the journal Nature Communications, focus on an enzyme called flap endonuclease 1, or FEN1. Using a combination of crystallographic, biochemical, and genetic analyses, researchers at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) showed that phosphate steering kept FEN1 in line and working properly.
"FEN1, like many DNA replication and repair proteins, have paradoxical roles relevant to cancer," said study lead author Susan Tsutakawa, a biochemist at Berkeley Lab's Molecular Biophysics and Integrated Bioimaging Division. "A mistake by FEN1 could damage the DNA, leading to the development of cancer. On the other side, many cancers need replication and repair proteins to survive and to repair DNA damaged from cancer treatments. New evidence shows that phosphate steering helps ensure that FEN1 behaves as it should to prevent genome instability."
During the process of replication, double-stranded DNA unzips to expose the nucleotides along its two separate strands. In that process, flaps of single-stranded DNA are created. The job of FEN1 is to remove those flaps by positioning metal catalysts so that they can break down the phosphodiester bonds that make up the backbone of nucleic acid strands. This cleavage action occurs in the duplex DNA near the junction with the single-stranded flap.
Flaps that remain uncleaved can lead to toxic DNA damage that either kill the cell or cause extensive mutations. For example, trinucleotide repeat expansions, a mutation associated with disorders such as Huntington's disease and fragile X syndrome, are characterized by the failure of FEN1 to cut off the excess strand.
"What had been unclear before our study was how FEN1 was able to identify its exact target while preventing the indiscriminate cutting of single-stranded flaps," said Tsutakawa. "There must be a way for this protein to not shred similar targets, such as single-stranded RNA or DNA. Getting that right is critical."
Tsutakawa worked with corresponding author John Tainer, Berkeley Lab research scientist and a professor at the University of Texas, at the Advanced Light Source, a DOE Office of Science User Facility that produces extremely bright X-ray beams suitable for solving the atomic structure of protein and DNA complexes. Using X-ray crystallography, they were able to get a molecular-level view of the FEN1 protein structure.
They determined that the single-stranded flap threaded through a small hole formed by the FEN1 protein. The size of the hole serves as an extra check that FEN1 is binding the correct target. However, they surprisingly found that the single-stranded flap is inverted such that the more vulnerable part of the DNA, the phosphodiester backbone, faces away from the metal catalysts, thereby reducing the chance of inadvertent incision.
The inversion is guided by a positively charged region in FEN1 that stabilizes the upside-down position and steers the negatively charged phosphodiester of the single-stranded DNA through the FEN1 tunnel.
"These metals are like scissors and will cut any DNA near them," said Tsutakawa. "The positively charged region in FEN1 acts like a magnet, pulling the flap away from these metals and protecting the flap from being cut. This is how FEN1 avoids cutting single-stranded DNA or RNA."
"This phosphate steering is a previously unknown mechanism for controlling the specificity of FEN1," she added. "Cancer cells need FEN proteins to replicate, so understanding how FEN1 works could help provide targets for research into treatments down the line."
In addition to Tainer, other corresponding authors of the study are Sergei Mirkin at Tufts University and Jane Grasby at the University of Sheffield. Other co-lead authors of the study are Mark Thompson at the University of Sheffield, Andrew Arvai at The Scripps Research Institute, and Alexander Neil at Tufts University.
The National Cancer Institute, the Biotechnology and Biological Sciences Research Council in the United Kingdom, and the King Abdullah University of Science and Technology in Saudi Arabia provided primary support for this work.
Lawrence Berkeley National Laboratory addresses the world's most urgent scientific challenges by advancing sustainable energy, protecting human health, creating new materials, and revealing the origin and fate of the universe. Founded in 1931, Berkeley Lab's scientific expertise has been recognized with 13 Nobel Prizes. The University of California manages Berkeley Lab for the U.S. Department of Energy's Office of Science. For more, visit http://www.
DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov.
Sarah Yang | EurekAlert!
Switch-in-a-cell electrifies life
18.12.2018 | Rice University
Plant biologists identify mechanism behind transition from insect to wind pollination
18.12.2018 | University of Toronto
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy